ZhuZhou QianJin Pharmaceutical (600479.SS) Earnings Analysis

ZhuZhou QianJin Pharmaceutical (600479.SS) has no confirmed upcoming earnings date. Trailing P/E 14.39.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 600479.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 600479.SS. This page updates as the calendar is published.

600479.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-06-300.1759 CNYn/an/an/a
2025-05-210.1497 CNYn/an/an/a
2025-03-310.1254 CNYn/an/an/a
2024-09-290.1203 CNYn/an/an/a

600479.SS valuation and analyst view

Trailing P/E14.39
Trailing EPS0.62925 CNY
Price / book1.53
Dividend yield3.94%
Market cap3.94B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is ZhuZhou QianJin Pharmaceutical (600479.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 600479.SS. This page updates as the calendar is published.

Did 600479.SS beat earnings last quarter?

Consensus estimate data was not available for 600479.SS's 2025-06-30 report.

What is 600479.SS's current P/E ratio and EPS?

600479.SS trades at a trailing P/E of 14.39 on trailing EPS of 0.6292498523198384 CNY.

What do analysts rate 600479.SS?

600479.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.